New drug reports
The Prescription Drug Price Transparency Act requires prescription drug manufacturers to report on new prescription drugs with a price exceeding $670 (the Medicare Part D specialty drug cost threshold). Reports must be submitted to the department within 30 days of the market entry date of the prescription drug meeting the reporting threshold.
Prescription drug reports will be posted to the department’s website no later than 90 days after the department received the filing. Any other information requested will be posted no later than 60 days after receiving the response. All other correspondence or records between the department and the reporting manufacturer will be posted as soon as practicable.
Information claimed to be a trade secret in a report filing, other information response, or correspondence will not be posted until a final determination has been made by the department or the director. Any information claimed to be a trade secret determined by the department to be exempt from disclosure will not be directly posted publicly, but will be generally described and include an explanation of the exemption by the department.
NEW: Available Information
View New Drug Reports (XLSX)
Information reported to the department in new drug reports will be posted regularly according to the timelines outlined above. Data claimed to be a trade secret in a report filing will not be posted until a final determination has been made by the department. The department is actively reviewing and requesting more information about the reports. Information will be updated as soon as possible.
The following table displays the name of the manufacturer and the prescription drug in reports received by the department on annual price increases for drugs priced at least $100 and experienced a net yearly increase.
Last updated: November 4, 2019.
For information on a specific drug, visit the following pages:
For general information on prescription drugs, visit the following pages: